Mildronate

Not to be confused with Medronate, a bisphosphonate that forms a complex with radioactive technetium to be used as a radiopharmaceutical.

Mildronate is an antischemic agent of a metabolic action (cardioprotector) produced by Grindex in Latvia. The active substance is trimethylhydrazinium propionate dihydrate.

Mechanism of action
Mildronate is a fatty acid oxidation inhibitor.

Indications

 * Cardiovascular diseases: chronic coronary heart disease, stable angina pectoris,chronic heart failure, functional cardiovascular disturbances,cardiomyopathy.
 * Acute and chronic ischemic cerebrovascular disturbances.
 * Mildronate is used also in the cases of decreased performance, physical and psychoemotional overload, and during recovery process.

Forms

 * 250 mg capsules N60
 * 500 mg capsules N60
 * Injection 10% 5 ml N10